期刊文献+

拓扑异构酶Ⅰ在病理性瘢痕组织中的表达

下载PDF
导出
摘要 目的探讨拓扑异构酶Ⅰ(TopoⅠ)在病理性瘢痕组织中的表达。方法用SP免疫组织化学染色法检测病理性瘢痕组织和正常皮肤组织标本各21例,了解TopoⅠ的表达情况。结果正常皮肤组角质形成细胞及成纤维细胞TopoⅠ阳性表达率均为14.3%。病理性瘢痕组角质形成细胞TopoⅠ阳性表达率为33.3%,与正常皮肤组比较差异无统计学意义(P>0.05);成纤维细胞TopoⅠ阳性总表达率为57.1%,与正常皮肤组比较差异有统计学意义(P<0.05)。结论在病理性瘢痕中,成纤维细胞的TopoⅠ表达明显高于正常皮肤,这为TopoⅠ抑制剂应用于瘢痕防治提供了理论依据。
作者 潘登 廖立新
出处 《实用临床医学(江西)》 CAS 2008年第5期18-19,33,F0002,共4页 Practical Clinical Medicine
  • 相关文献

参考文献9

  • 1Staley B E, Samowitz W S, Bronstein I B, et al. Expression of DNA Topoisomerase I and DNA Topoisomerase Ⅱ-alpha in Carcinoma of the Colon[J]. Mod Pathol, 1999,12(4) :356-361.
  • 2Chowdhury A R,Majumder H K. DNA Topoisomerases in Life and Death: Implications in Kinetoplastid Protozoa[J]. Curr Mol Med,2004 ,4(6) :711-722.
  • 3Lansiaux A, Laine W, Baldeyrou B, et al. DNA Topoisomerase Ⅱ Inhibition by Peroxisomicine A(1) and Its Radical Metabolite Induces Apoptotic Cell Death of HL-60 and HL-60/MX2 Human Leukemia Cells[J]. Chem Res Toxicol, 2001,14 (1):16-24.
  • 4Tretiakova M, Turkyilmaz M, Grushko T, et al. Topoisomerase IIalpha in Wilms' Tumour: Gene Alterations and Immunoexpression[J]. J Clin Pathol, 2006,59 (12) : 1272-1277.
  • 5Dark G G, Calvert A H, Grimshaw R, et al. Randomized Trial of Two Intravenous Schedules of the Topoisomerase I Inhibitor Liposomal Lurtotecan in Women with Relapsed Epithelial Ovarian Cancer:a Trial of the National Cancer Institute of Canada Clinical Trials Group[J]. J Clin Oncol, 2005,23 (9) : 1859-1866.
  • 6Coleman R L. Emerging Role of Topotecan in Front-line Treat-ment of Carcinoma Of the Ovary[J]. Oncologist. 2002,7 (5): 46-55.
  • 7Rajendra R, Gounder M K,Saleem A, et al. Differential Effects of the Breast Cancer Resistance Protein on the Cellular Accumulation and Cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin[J]. Cancer Res,2003,15,63(12):3228-3233.
  • 8Koopman M, Antonlni N F, Douma J, et al. Randomised Study of Sequential Versus Combination Chemotherapy with Capecitabine,Irinotecan and Oxaliplatin in Advanced Colorectal Cancer, an Interim Safety Analysis. A Dutch Colorectal Cancer Group (DCCG) phase Ⅲ studv[J]. Ann Oncol, 2006,17 (10) :1523-1528.
  • 9Al-Attar A,Mess S,Thomassen J M,et al. Keloid Pathogenesis and Treatment[J]. Plast Reconstr Surg, 2006, 117 (1): 286-300.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部